Portage Biotech Inc (PRTG) — Long-term Investment Intensity
Portage Biotech Inc (PRTG) has a Long-term Investment Intensity of 11.9% as of December 2023. Long-term investments of $6.00 Million represent 11.9% of total assets of $50.58 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Portage Biotech Inc (PRTG) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Portage Biotech Inc Long-term Investment Intensity (2017–2023)
This chart shows how Portage Biotech Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2017 to 2023. As of December 2023, the intensity stands at 11.9%, reflecting long-term investments of $6.00 Million against total assets of $50.58 Million USD. Explore PRTG debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Portage Biotech Inc (2017–2023)
The table below presents the year-by-year Long-term Investment Intensity for Portage Biotech Inc from 2017 to 2023, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Portage Biotech Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 2.9% | $2.89 Million | $99.13 Million | ▼ -1.7 pp |
| 2022 | 4.7% | $9.08 Million | $194.66 Million | ▼ -0.6 pp |
| 2021 | 5.2% | $9.14 Million | $174.86 Million | ▲ +0.2 pp |
| 2020 | 5.0% | $8.63 Million | $173.17 Million | ▲ +1.3 pp |
| 2019 | 3.7% | $6.41 Million | $173.72 Million | ▼ -10.1 pp |
| 2018 | 13.8% | $1.38 Million | $10.00 Million | ▲ +12.6 pp |
| 2017 | 1.2% | $700.00K | $59.90 Million | — |